Steroidal and pregnane glycosides from Ypsilandra thibetica

  • Hai-Yang LIU ,  
  • Chang-Xiang CHEN ,  
  • Yi LU ,  
  • Jun-Yun YANG ,  
  • Wei NI
  •     

Abstract

The whole plants of Ypsilandra thibetica have been analyzed as part of a systematic study on saponin constituents of medicinal plants. This has resulted in the isolation of two new bisdesmosidic furostanol saponins, named ypsilandroside P(1) and ypsilandroside Q(2), and one new pregnane glycoside, named ypsilandroside R(3), together with nine known steroidal glycosides. Their structures were elucidated on the basis of extensive spectroscopic analysis, including that of 2D NMR data, and the results of acidic hydrolysis. Ypsilandroside P(1) was cytotoxicity against two human tumor cell lines.

Keywords

Ypsilandra thibetica    Liliaceae    furostanol glycoside    pregnane glycoside    ypsilandroside    

Introduction

In a continuation of our study on saponin constituents of medicinal plants, we have examined the saponin riched fraction prepared from the EtOH extract of the air-dried whole plants of Ypsilandra thibetica (Liliaceae). This perennial plant distributes in southwestern China and has been used as hemostatic agent in Chinese folk medicine.1, 2 In our recent study, we found that this species was a rich source of steroidal saponins. Two sapogenin, 22 spirostanol saponins, and two C-22 steroidal lactone glycosides were obtained from the title plants.3-6 Further phytochemical investigation has been carried out on this species, with particular attention to the steroidal glycoside constituents, and has resulted in the isolation of two new bisdesmosidic furostanol saponins (1 and 2) and one new pregnane glycoside (3), together with nine known steroidal glycosides: protoprogenin Ⅱ (4), 7 proto-Pb (5), 8 saponin Th (6), 9 pseudoproto Pb (7), 10pregnane 5, 16-dien-3β-ol-20-oxo 3-O-α-L-rhamnopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→4)-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranoside (8), 11 smilaxchinoside B (9), 12 parispseudoside C (10), 13 parispseudoside A (11), 13 and 26-O-β-D-glucopyranosyl-3β, 26-dihydroxy-20, 22-seco-25(R)-furost-5-en-20, 22-dione 3-O-α-Lrhamnopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→4)-[α-Lrhamnopyranosyl-(1→2)]-β-D-glucopyranoside (12).14 This paper reports the isolation, structural determination, and cytotoxic activity of these glycosides.

Results and Discussion

Compound 1, obtained as a white amorphous powder, gave a pseudo-molecular ion peak [M – H] at m/z 1207.5736 (calcd. 1207.5747) in its HRESIMS. Combined with 13C NMR spectroscopic data (Table 2), its molecular formula was determined as C57H92O27. The 1H NMR spectrum of 1 (Table 1) showed signals of four steroid methyl groups at δH 0.97 (3H, d, J = 6.5 Hz, Me-27), 1.06 (3H, s, Me-19), 1.15 (3H, s, Me-18), and 1.53 (3H, d, J = 6.7 Hz, Me-21), an olefinic proton at δH 5.22 (1H, br. s), as well as signals for five anomeric proton signals at δH 4.80 (1H, d, J = 7.7 Hz, H-1'''''), 4.93 (1H, d, J = 7.2 Hz, H-1'), 5.84 (1H, br. s, H-1'''), 6.29 (1H, br. s, H-1''''), and 6.41 (1H, br. s, H-1''). The three methyl carbon signals at δC 18.7, 18.9, and 18.5 and their corresponding proton signals at δH 1.58 (3H, d, J = 5.2 Hz, H-6''), 1.58 (3H, d, J = 5.2 Hz, H-6'''), and 1.75 (3H, d, J = 6.1 Hz, H-6'''') indicated that 1 had three deoxy sugars. The monosaccharides of the acidic hydrolysate of 1 were identified as D-glucose and L-rhamnose on the basis of GC analysis and comparison with authentic standards. The above 1H NMR and chemical data, together with an acetalic carbon signal at δC 110.9 in the 13C NMR spectrum15 and a positive coloration with Ehrlich reagent, 16, 17 indicated 1 to be a furostanol saponin with up to five monosaccharides. A comparison of the 1H and 13C spectroscopic signals of the aglycone moiety of 1 with ProtoPb (5)8indicated that the signals were similar except for the presence of a carbonyl group (δC 213.1). In the HMBC spectrum (Figure 1), the long-range correlations from δH 1.15 (Me-18, s) to δC 213.1 (C-12, s), 55.4 (C-13, s), 56.0 (C-14, d), and 54.9 (C-17, d) indicated that the carbonyl group was attached at C-12 of the aglycone of 1. The configuration of the methyl group at C-25 is R on the basis of the proton signals of C-26 at δH 3.94 (1H, 26-Ha) and 3.60 (1H, 26-Hb), and the difference (∆ab) of the proton signals at C-26 was 0.34.18, 19 From the above evidence, the aglycone of 1 was identified as (25R)-furost-5-en-3β, 22α, 26-triol-12-one.

Fig. 1

Selected HMBC correlations of conpound 1.

Table 1

1H NMR spectral data for compounds 1–3 (δ in ppm, J in Hz, C5D5N)a

Pos. 1b 2c 3c Pos. 1b 2c 3c
1a 1.96, m 1.53, m 1.47, m Glc-1' 4.93, d(7.2) 4.91, d (7.9) 4.93, d(7.4)
1b 0.89, m 0.89, m 0.87, m 2' 4.18, m 4.20, m 4.21, m
2a 2.00, m 2.00, m 1.63, m 3' 4.20, m 4.23, m 4.20, m
2b 1.78, m 1.88, m 1.41, m 4' 4.39, m 4.41, m 4.40, m
3 3.81, m 3.82, m 3.81, m 5' 3.60, br. d (9.1) 3.61, m 3.59, br. s
4a 2.80, m 2.81, dd (11.0, 2.4) 2.82, dd (13.3, 1.8) 6'a 4.17, d (14.2) 4.17, d (12.3) 4.18, m
4b 2.68, m 2.68, t (11.0) 2.68, dd (12.3, 5.9) 6' b 4.02, m 4.04, m 4.03, d(11.1)
6 5.22, br. s 5.28, br. s 5.30, br. s Rha-1'' 6.41, br. s 6.41, br. s 6.41, br. s
7a 1.87, m 1.89, m (2H) 1.90, m 2'' 4.86, m 4.85, m 4.85, m
7b 1.43, m 1.52, m 3'' 4.62, m 4.63, m 4.63, m
8 1.85, m 1.79, m 1.86, m 4'' 4.35, m 4.37, m 4.36, m
9 1.30, m 1.32, m 1.38, m 5'' 4.93, m 4.95, m 4.94, m
11a 2.56, t (13.5) 2.53, t (14.0) 2.64, t (13.5) 6'' 1.58, d (5.2) 1.59, d (5.9) 1.59, d (5.6)
11b 2.30, dd (14.4, 5.6) 2.31, dd (14.5, 5.7) 2.25, dd (13.5, 6.3) Rha-1''' 5.84, br. s 5.84, br. s 5.83, br. s
14 1.41, m 1.23, m 1.58, m 2''' 4.51, m 4.51, m 4.53, m
15a 2.09, m 2.20, m 2.25, m 3''' 4.55, m 4.56, m 4.55, m
15b 1.64, m 1.67, m 2.07, m 4''' 4.44, m 4.45, m 4.43, m
16 4.88, m 4.84, m 6.54, s 5''' 4.92, m 4.93, m 4.93, m
17 2.94, t (7.5) 3.45, d (10.2) 6''' 1.58, d (5.2) 1.59, d (5.9) 1.59, d (5.6)
18 1.15, s 0.95, s 1.33, s Rha-1'''' 6.29, br. s 6.30, br. s 6.29, br. s
19 1.06, s 1.07, s 1.07, s 2'''' 4.90, m 4.90, m 4.90, m
20 2.20, dd (13.2, 6.5) 3'''' 4.52, m 4.53, m 4.53, m
21 1.53, d (6.7) 1.74, s 2.32, s 4'''' 4.30, m 4.31, m 4.31, m
23a 2.05, m 2.20, m (2H) 5'''' 4.36, m 4.38, m 4.36, m
23b 1.52, m 6'''' 1.75, d (6.1) 1.76, d (6.2) 1.76, d (6.2)
24a 2.04, m 1.89, m Glc-1'''' 4.80, d (7.7) 4.84, d (7.8)
24b 1.66, m 1.45, m 2'''' 3.60, br. d (9.1) 3.60, dd (9.4, 5.4)
25 1.92, m 1.93, m 3'''' 4.24, m 4.26, m
26a 3.94, dd (9.1, 7.1) 3.95, dd (9.4, 7.1) 4'''' 4.21, m 4.25, m
26b 3.60, dd (9.1, 5.8) 3.59, dd (9.4, 5.4) 5'''' 3.94, m 3.96, m
27 0.97, d (6.5) 1.01, d (6.6) 6''''a 4.54, m 4.58, m
6''''b 4.38, m 4.40, m
aAssignments based on 2D NMR spectra; bRecorded at 400 MHz; cRecorded at 500 MHz.

Table 2

13C NMR spectral data for compounds 1–3 (C5D5N)

Pos. 1a 2b 3b Pos. 1a 2b 3b
1 37.2, CH2 37.1, CH2 37.0, CH2 Glc-1' 100.4, CH 100.4, CH 100.4, CH
2 30.0, CH2 30.0, CH2 29.9, CH2 2' 78.0, CH 77.9, CH 78.0, CH
3 77.8, CH 77.9, CH 77.9, CH 3' 77.7, CH 77.7, CH 77.8, CH
4 38.8, CH2 38.8, CH2 38.8, CH2 4' 77.8, CH 77.8, CH 77.9, CH
5 140.6, C 140.7, C 141.1, C 5' 77.1, CH 77.1, CH 77.1, CH
6 121.7, CH 121.6, CH 121.5, CH 6, 61.2, CH2 61.3, CH2 61.3, CH2
7 31.9, CH2 31.9, CH2 31.4, CH2 Rha-1'' 102.3, CH 102.2, CH 102.2, CH
8 31.0, CH 30.8, CH 30.2, CH 2'' 72.6, CH 72.5, CH 72.5, CH
9 52.4, CH 52.4, CH 53.8, CH 3'' 72.7, CH 72.6, CH 72.7, CH
10 37.7, C 37.8, C 38.0, C 4'' 74.2, CH 74.1, CH 74.2, CH
11 37.6, CH2 37.7, CH2 37.8, CH2 5'' 69.5, CH 69.6, CH 69.6, CH
12 213.1, C 212.8, C 209.2, C 6'' 18.7, CH3 18.7, CH3 18.7, CH3
13 55.4, C 57.2, C 61.3, C Rha-1''' 102.3, CH 102.3, CH 102.3, CH
14 56.0, CH 54.4, CH 56.2, CH 2''' 72.9, CH 72.9, CH 72.9, CH
15 31.9, CH2 34.0, CH2 31.8, CH2 3''' 73.4, CH 73.3, CH 73.3, CH
16 79.8, CH 83.1, CH 142.8, CH 4''' 80.5, CH 80.4, CH 80.4, CH
17 54.9, CH 56.1, CH 150.7, C 5, ,, 68.4, CH 68.4, CH 68.4, CH
18 16.1, CH3 14.0, CH3 16.4, CH3 6''' 18.9, CH3 18.9, CH3 18.8, CH3
19 19.0, CH3 18.9, CH3 18.9, CH3 Rha-1'''' 103.4, CH 103.3, CH 103.3, CH
20 41.4, CH 103.1, C 196.0, C 2'''' 72.7, CH 72.6, CH 72.5, CH
21 15.3, CH3 11.6, CH3 27.7, CH3 3'''' 72.9, CH 72.9, CH 72.9, CH
22 110.9, C 153.2, C 4'''' 74.0, CH 74.0, CH 74.1, CH
23 37.1, CH2 23.8, CH2 5'''' 70.5, CH 70.4, CH 70.5, CH
24 28.4, CH2 31.4, CH2 6'''' 18.5, CH3 18.5, CH3 18.5, CH3
25 34.3, CH 33.6, CH Glc-1'''' 105.0, CH 105.0, CH
26 75.4, CH2 75.2, CH2 2'''' 75.3, CH 75.0, CH
27 17.5, CH3 17.3, CH3 3'''' 78.7, CH 78.6, CH
4'''' 71.7, CH 71.7, CH
5'''' 78.6, CH 78.5, CH
6'''' 62.9, CH2 62.9, CH2
aRecorded at 100 MHz; bRecorded at 125 MHz.

Comparison of the carbon chemical shift thus assigned with those of the reference methyl glycosides, 15, 19 taking into account the known effects of O-glycosylation, indicated that 1 contained a terminal β-D-glucopyranosyl units, two terminal α-L-rhamnopyranosyl unit, a C-4 substituted α-L-rhamnopyranosyl unit, and a C-2 and C-4 disubstituted β-Dglucopyranosyl unit. The β-configuration of the anomeric protons of the glucopyranosyl residue were assigned based on its J1H-2H value (J = 7.2~7.7 Hz), while the anomeric configuration of the three rhamnopyranosyls were determined as α-oriented on the ground the chemical shift values of the C-3", C-5", C-3''', C-5''', C-3'''', and C-5'''' with those of the corresponding carbons of methyl α- and β-rhamnopyranoside.20, 21 In the HMBC spectrum, a correlation peak between the signals at δH 4.80 (H-1 of terminal glucosyl) and δC 75.4 (C-26 of aglycon) implied that one glucose unit was attached at C-26 of the aglycon, which is a structural feature most frequently encountered in the plant furostanol saponins.15 Consequently, a tetraglycoside was assumed to be located at C-3 of the aglycon. The sequence of the tetrasaccharide, which was the same as the known compounds 5–12, was established from the further HMBC correlations: H-1'(δH 4.93) of Glc with C-3 (δC 77.8) of the aglycone, H-1''(δH 6.41) of 2'-Rha with C-2'(δC 78.0) of Glc, H-1'''(δH 5.84) of 4'-Rha with C-4' (δC 77.8) of Glc, and H-1''''(δH 6.29) of 4''-Rha with C-4'''(δC 80.5) of 4'-Rha. Therefore, 1 was determined to be 26-O-β-D-glucopyranosyl-(25R)-3β, 22α, 26-trihydroxyfurost-5-en-12-one 3-O-α-L-rhamnopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside, and named ypsilandroside P.

Compound 2 displayed a [M – H] ion at m/z 1189.5645 (calcd. for C57H89O26, 1189.5642) in the HRESIMS and gave a red color with Ehrlich's reagent. The NMR spectral data suggested 2 is a furostanol saponin closely related to 1. It differed from 1 in the presence of one more olefinic functionality [δC 153.2 (s) and 103.1 (s)] in addition to the 5(6)-en group. Furthermore, the Me-21 methyl doublet signal observed at δH 1.53 (J = 6.7 Hz) in the 1H NMR spectrum of 1 was absent from 2, but was replaced by a methyl singlet at δH 1.74. These data were suggestive of 2 being the corresponding Δ20(22)-furostanol saponin of 1, which was confirmed by the mass difference of m/z = 18 and HMBC correlations. In the HMBC spectrum of 2, the correlations of Me-21 (δH 1.74) with C-17 (δC 56.1), C-20 (δC 103.1), and C-22 (δC 153.2) were observed. Thus, the structure of 2 was established as 26-O-β-D-β-D-glucopyranosyl-(25R)-3β, 26-dihydroxyfurost-5, 20 (22)-diene-12-one 3-O-α-L-rhamnopyranosyl-(1→4)-α-Lrhamnopyranosyl-(1→4)-[α-L-rhamnopyranosyl-(1→2)]-β-Dglucopyranoside, and named ypsilandroside Q.

Compound 3 had a molecular formula of C45H68O20, established by analysis of HRESIMS (m/z 963.3953 [M + Cl], calcd. 963.3992) and 13C NMR spectrum (45 signals). The 1H NMR spectrum of 3 displayed two three-proton singlet signals at δH 1.07 (s) and 1.33 (s), indicating the presence of two angular methyl groups, and a methyl singlet at δH 2.32 (s) attached to a deshielding moiety, as well as four anomeric proton signals at δH 4.93 (1H, d, J = 7.4 Hz), 5.83 (1H, br. s), 6.29 (1H, br. s), and 6.41 (1H, br. s). The existence of an α, β-unsaturated carbonyl group was verified by the IR (1657 cm−1), UV [227 nm (logε 2.8)], and 13C NMR [δC 196.0 (C=O), 150.7 (C), and 142.8 (CH)] spectra. These spectral data and comparison with those of the known compound 811 indicated that 3 differed from 8 by the presence of a carbonyl group (δC 209.2) instead of a methylene moiety at C-12 in the latter. The HMBC correlations of δH 1.33 (Me-18) with δC 209.2 (C-12, s), 61.3 (C-13, s), 56.2 (C-14, d), 150.7 (C-17, s) indicated that the location of the carbonyl group at C-12. Thus, the aglycone of 3 was identified as 3α-hydroxypregna-5, 16-dien-12, 20-dione. The 1H and 13C NMR shifts of the tetraglycoside moiety linked to C-3 of the pregnane were superimposable on those of 1, 2, and 5–12. On the basis of all the information above, the structure of 3 was characterized as pregnane 5, 16-dien-3β-ol-12, 20-dione 3-O-α-L-rhamnopyranosyl-(1→4)-α-Lrhamnopyranosyl-(1→4)-[α-L-rhamnopyranosyl-(1→2)]-β-Dglucopyranoside, and named ypsilandroside R.

The cytotoxic activities of saponins 1, 2, and 12 against the growth of human tumor cell lines (A549 and HL-60) were evaluated. The results indicated that only compound 1 showed 86.4% inhibition to A549 cell lines and 75.9% inhibition to HL-60 cell lines at the tested concentration (10 μM).

Experimental Section

General Experimental Procedures. Optical rotations were measured on a Jasco P-1020 automatic digital polarimeter. UV spectra were measured using a Shimadzu UV-2401PC spectrophotometer. IR spectra were measured on a Bio-Rad FTS-135 spectrometer with KBr pellets. NMR spectra were run on Bruker AM-400 and DRX-500 instruments with TMS as internal standard. FAB-MS spectra were recorded on a VG Auto Spec-300 spectrometer, HRESIMS spectra were recorded on an API Qstar Pulsar instrument. Column chromatography (CC) was performed over silica gel (200–300 mesh, 10–40 μm, Qingdao Marine Chemical Co., China), Rp-18 (40–63 μm, Merck), and Sephadex LH-20 (GE Healthcare, Sweden). TLC was performed on HSGF254 (0.2 mm, Qingdao Marine Chemical Co., China) or Rp-18 F254 (0.25 mm, Merck). Semipreparative HPLC was run on Agilent 1100 liquid chromatograph with diode array detector (DAD) setting at 200nm and 254 nm, ZORBAX SB-C18 (5 μm) column (25 cm × 9.4 mm i.d.). GC analysis was performed on a Shimadzu GC-2010 gas chromatograph equipped with an H2 flame ionization detector.

Plant Material. The plant material of Y. thibetica was collected in November 2006 from Luding County, Sichuan Province, China, and identified by Prof. Xin-Qi Chen, Institute of Botany, Chinese Academy of Sciences, Beijing. A voucher specimen (No. HY0002) was deposited at the State Key Laboratory of Phytochemistry and Plant Resources in West China.

Extraction and Isolation. The air-dried whole plants of Y. thibetica (10 kg) were extracted three times with 70% EtOH (50 L × 3) under reflux for a total of 6 h and the combined extract was concentrated under reduced pressure. Then the concentrated extract was loaded onto a macroporous resin column (YWD-3F) and eluted successively with H2O, 40% EtOH (F1 fraction), 70% EtOH (F2 fraction), and 95% EtOH (F3 fraction), respectively. The 40% EtOH elutes were evaporated to dryness. Fraction F1 (33 g) was fractioned by silica gel column and eluted with a gradient of CHCl3-MeOH-H2O (8:2:0.2→7:3:0.5, v/v) to get two subfractions (F11 and F12). Fraction F11 was subjected to column chromatography on Rp-18 gel (MPLC, MeOH-H2O 4:6→6.5:3.5) and semipreparative HPLC (MeOH-H2O 38:62 v/v; flow rate: 3 mL.min−1) to obtain 3 (14 mg), 4 (28 mg), and 8 (19 mg). Fraction F12 was chromatographed over Rp-18 gel (MPLC, MeOH-H2O 3:7→7:3) and semi-preparative HPLC (MeCNH2O 20:80→35:65 v/v; flow rate: 3 mL.min−1) to yield 1 (17 mg), 2 (8 mg), 5 (43 mg), 6 (80 mg), 7 (23 mg), 9 (20 mg), 10 (17 mg), 11 (18 mg), and 12 (24 mg).

Ypsilandroside P (1): white amorphous powder; [α]D24 −65.0 (c 0.26, MeOH); IR (KBr) νmax 3431, 2934, 1706, 1640, 1453, 1381, 1130, 1044, 985, 911, 839, 804 cm−1 (intensity: 839 > 911); 1H and 13C NMR data see Tables 1 and 2; negative FABMS m/z 1208 M, 1062 [M − 146], 915 [M − H − 2 × 146], 769 [M H − 3 × 146]; negative ion HRESIMS m/z 1207.5736 (calcd. for C57H91O27 [M − H], 1207.5747).

Ypsilandroside Q (2): white amorphous powder; α [α]D24 −66.8 (c 0.47, MeOH); IR (KBr) νmax 3426, 2933, 1707, 1640, 1453, 1382, 1131, 1043, 984, 911, 841, 804 cm−1 (intensity: 841 > 911); 1H and 13C NMR data see Tables 1 and 2; negative FABMS m/z 1190 [M], 1043 [M − H − 146], 897 [M − H − 2 × 146]; negative ion HRESIMS m/z 1189.5645 (calcd. for C57H89O26 [M − H], 1189.5642).

Ypsilandroside R (3): white amorphous powder; αD22 −58.3 (c 0.12, MeOH); UV (MeOH) λmax (log ε) 227 (2.8) nm; IR (KBr) νmax 3418, 2934, 1713, 1657, 1376, 1132, 1053, 983 cm−1; 1H and 13C NMR data see Tables 1 and 2; negative FABMS m/z 927 [M − H], 781 [M − H − 146], 635 [M − H − 2 × 146]; negative ion HRESIMS m/z 963.3953 (calcd. for C45H68O20Cl [[M + Cl]], 963.3992).

Acid Hydrolysis of Compounds 1–3 and GC Analysis. Compounds 1–3 (4 mg each) were refluxed with 4 M TFAdioxane (1:1 v/v, 2 mL) on water bath for 4h. The reaction mixture was neutralized with 1 M NaOH and filtered. The filtrate was extracted with CHCl3 and H2O. The H2O-soluble fraction was evaporated to dryness. The dried sugar residues was diluted in 1 mL pyridine without water and treated with 0.5 mL trimethyl-chlorsilan (TMCS) and stirred at 60℃ for 5 min. After drying the solution with a stream of N2, the residue was extracted with ether (1 mL). The ether layer was analyzed by GC under the following conditions: column, SGE AC-10 quartz capillary column (30 m × 0.32 mm × 0.25 μm); column temperature 180–280℃; programmed increase, 3 ℃/min; carrier gas, N2 (2 ml/min); injector and detector temperature, 250℃; injection volume, 2 μL; split ratio, 1/50. Peaks of the hydrolysate were detected by comparison with retention times of authentic samples of glucose and rhamnose after treatment with trimethyl-chlorsilan (TMCS) in pyridine. The absolute configurations of the sugar residues were determined to be Lrhamnose (tR 7.67 min) and D-glucose (tR 14.22 min).

Cell-Growth Inhibition Assay. Growth inhibition of compounds on tumor cells was determined by microculture 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazolium hydrobromide (MTT) assay.22

Electronic Supplementary Material

Supplementary material is available in the online version of this article at http://dx.doi.org/ 10.1007/s13659-011-0039-z and is accessible for authorized users.

Notes

Acknowledgments

This work was financially supported by National Natural Science Funding of China (No. 31170333), the Natural Science Foundation of Yunnan Province (No. 2009CC019), the West Light Foundation of the Chinese Academy of Sciences (No. 2908025712W1), and a fund (No.540806321211) of State Key Laboratory of Phytochemistry and Plant Resources in West China, Germplasm Bank of Wild Species and CAS Innovation Program of Kunming Institute of Botany.

References

  1. 1.
    Hou K. Z. Dictionary of the Families and Genera of Chinese Seed Plants (Second Edition); Science Press: Beijing, 1982; pp 521. PubMed Google Scholar
  2. 2.
    Jiangsu New Medical College. Dictionary of Traditional Chinese Crude Drugs; Shanghai Press of Science and Technology: Shanghai, 1977; pp 1841. PubMed Google Scholar
  3. 3.
    B. B. Xie, H. Y. Liu, W. Ni, C. X. Chen, Y. Lü, L. Wu, Q. T. Zheng, Chem. Biodivers. 3, 1211-1218 (2006) CrossRef PubMed Google Scholar
  4. 4.
    B. B. Xie, H. Y. Liu, W. Ni, C. X. Chen, Steroids 74, 950-955 (2009) CrossRef PubMed Google Scholar
  5. 5.
    Y. Lu, C. X. Chen, W. Ni, Y. Hua, H. Y. Liu, Steroids 75, 982-987 (2010) CrossRef PubMed Google Scholar
  6. 6.
    Y. Lu, B. B. Xie, C. X. Chen, W. Ni, Y. Hua, H. Y. Liu, Helv. Chim. Acta 94, 92-97 (2011) CrossRef PubMed Google Scholar
  7. 7.
    Y. Zhao, B. Feng, L. P. Kang, B. Li, H. Z. Huang, Y. W. Cong, B. P. Ma, Chin. J. Nat. Med. 7, 381-389 (2009) PubMed Google Scholar
  8. 8.
    Y. Zhao, L. P. Kang, Y. X. Liu, Y. G. Liang, D. W. Tan, Z. Y. Yu, Y. W. Cong, B. P. Ma, Planta Med. 75, 356-363 (2009) CrossRef PubMed Google Scholar
  9. 9.
    T. Nohara, Y. Ito, H. Seike, T. Komori, M. Moriyama, Y. Gomita, T. Kawasaki, Chem. Pharm. Bull. 30, 1851-1856 (1982) CrossRef PubMed Google Scholar
  10. 10.
    Y. Hirai, S. Sanada, Y. Ida, J. Shoji, Chem. Pharm. Bull. 34, 82-87 (1986) CrossRef PubMed Google Scholar
  11. 11.
    C. X. Chen, J. Zhou, Y. T. Zhang, Y. Y. Zhao, Acta Bot. Yunnan. 12, 323-329 (1990) PubMed Google Scholar
  12. 12.
    B. Shao, H. Guo, Y. Cui, M. Ye, J. Han, D. Guo, Phytochemistry 68, 623-630 (2007) CrossRef PubMed Google Scholar
  13. 13.
    C. M. Xiao, J. Huang, X. M. Zhong, X. Y. Tan, P. C. Deng, Helv. Chim. Acta 92, 2587-2595 (2009) CrossRef PubMed Google Scholar
  14. 14.
    M. Sautour, A. C. Mitaine-Offer, T. Miyamoto, A. Dongmo, M. A. Lacaille-Dubois, Chem. Pharm. Bull. 52, 1353-1355 (2004) CrossRef PubMed Google Scholar
  15. 15.
    P. K. Agrawal, D. C. Jain, R. K. Gupta, R. S. Thakur, Phytochemistry 24, 2479-2496 (1985) CrossRef PubMed Google Scholar
  16. 16.
    S. Kiyosawa, M. Hutoh, T. Komori, T. Nohara, I. Hosokawa, T. Kawasaki, Chem. Pharm. Bull. 16, 1162-1164 (1968) CrossRef PubMed Google Scholar
  17. 17.
    T. Nohara, K. Miyahara, T. Kawasaki, Chem. Pharm. Bull. 23, 872-885 (1975) CrossRef PubMed Google Scholar
  18. 18.
    P. K. Agrawal, Magn. Reson. Chem. 42, 990-993 (2004) CrossRef PubMed Google Scholar
  19. 19.
    P. K. Agrawal, Steroids 70, 715-724 (2005) CrossRef PubMed Google Scholar
  20. 20.
    P. K. Agrawal, Phytochemistry 31, 3307-3330 (1992) CrossRef PubMed Google Scholar
  21. 21.
    R. Kasai, M. Okihara, J. Asakawa, K. Mizutani, O. Tanaka, Tetrahedron 35, 1427-1432 (1979) CrossRef PubMed Google Scholar
  22. 22.
    T. Mosmman, J. Immunol. Methods 65, 55-63 (1983) CrossRef PubMed Google Scholar

Copyright information

© The Author(s) 2012

Open Access

This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Authors and Affiliations

  • Hai-Yang LIU
  • Chang-Xiang CHEN
  • Yi LU
  • Jun-Yun YANG
  • Wei NI
  •     
    State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China